Thrombin- and Factor Xa–Induced DNA Synthesis Is Mediated by Transactivation of Fibroblast Growth Factor Receptor-1 in Human Vascular Smooth Muscle Cells
- 20 February 2004
- journal article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 94 (3), 340-345
- https://doi.org/10.1161/01.res.0000111805.09592.d8
Abstract
Thrombin and factor Xa (FXa) are agonists for G protein–coupled receptors (GPRCs) and may contribute to vascular lesion formation by stimulating proliferation of vascular smooth muscle cells (SMCs). Mitogenic signaling of GPCRs requires transactivation of receptor tyrosine kinases (RTKs). In rat SMCs, thrombin transactivates the epidermal growth factor receptor (EGFR) via a pathway that involves heparin-binding EGF-like growth factor (HB-EGF) as ligand for EGFR. The purpose of this study was to investigate in human SMCs the role of receptor transactivation in the mitogenic response to thrombin and FXa. Thrombin (10 nmol/L) and FXa (100 nmol/L) cause a 3.3- and 2.6-fold increase in DNA synthesis, respectively. In human SMCs, neither thrombin nor FXa causes EGFR phosphorylation, and blockade of EGFR kinase does not inhibit DNA synthesis. However, DNA synthesis and phosphorylation of fibroblast growth factor receptor-1 (FGFR-1) induced by thrombin or FXa are inhibited by antibodies neutralizing basic fibroblast growth factor (bFGF) or by heparin. Hirudin inhibits thrombin-, but not FXa-induced mitogenesis, indicating that FXa acts independently of thrombin. We further demonstrate by ELISA that upon thrombin and FXa stimulation, bFGF is released and binds to the extracellular matrix. Our data suggest that in human vascular SMCs, both thrombin and FXa rapidly release bFGF into the pericellular matrix. This is followed by transactivation of the FGFR-1 and increased proliferation. Heparin may inhibit the mitogenic effects of thrombin and FXa in human SMCs by preventing bFGF binding to FGFR-1.Keywords
This publication has 25 references indexed in Scilit:
- Differential Actions of PAR 2 and PAR 1 in Stimulating Human Endothelial Cell Exocytosis and PermeabilityCirculation Research, 2003
- Protease-Activated Receptor Mediated RhoA Signaling and Cytoskeletal Reorganization in LNCaP CellsBiochemistry, 2002
- Protease-Activated Receptor-1–Mediated DNA Synthesis in Cardiac Fibroblast Is via Epidermal Growth Factor Receptor TransactivationCirculation Research, 2002
- Cellular Effects of Factor Xa on Vascular Smooth Muscle Cells-Inhibition by Heparins?Seminars in Thrombosis and Hemostasis, 2001
- Fibroblast growth factor-2The International Journal of Biochemistry & Cell Biology, 1999
- The Nuclear Trafficking of Extracellular Fibroblast Growth Factor (FGF)-1 Correlates with the Perinuclear Association of the FGF Receptor-1α Isoforms but Not the FGF Receptor-1β IsoformsPublished by Elsevier ,1996
- Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.The Journal of cell biology, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Inhibition of vascular smooth muscle cell migration by heparin‐like glycosaminoglycansJournal of Cellular Physiology, 1984
- Suppression by heparin of smooth muscle cell proliferation in injured arteriesNature, 1977